344 related articles for article (PubMed ID: 29198053)
1. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
Lobon-Iglesias MJ; Giraud G; Castel D; Philippe C; Debily MA; Briandet C; Fouyssac F; de Carli E; Dufour C; Valteau-Couanet D; Sainte-Rose C; Blauwblomme T; Beccaria K; Zerah M; Puget S; Calmon R; Boddaert N; Bolle S; Varlet P; Grill J
J Neurooncol; 2018 Mar; 137(1):111-118. PubMed ID: 29198053
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
Hoffman LM; Veldhuijzen van Zanten SEM; Colditz N; Baugh J; Chaney B; Hoffmann M; Lane A; Fuller C; Miles L; Hawkins C; Bartels U; Bouffet E; Goldman S; Leary S; Foreman NK; Packer R; Warren KE; Broniscer A; Kieran MW; Minturn J; Comito M; Broxson E; Shih CS; Khatua S; Chintagumpala M; Carret AS; Escorza NY; Hassall T; Ziegler DS; Gottardo N; Dholaria H; Doughman R; Benesch M; Drissi R; Nazarian J; Jabado N; Boddaert N; Varlet P; Giraud G; Castel D; Puget S; Jones C; Hulleman E; Modena P; Giagnacovo M; Antonelli M; Pietsch T; Gielen GH; Jones DTW; Sturm D; Pfister SM; Gerber NU; Grotzer MA; Pfaff E; von Bueren AO; Hargrave D; Solanki GA; Jadrijevic Cvrlje F; Kaspers GJL; Vandertop WP; Grill J; Bailey S; Biassoni V; Massimino M; Calmon R; Sanchez E; Bison B; Warmuth-Metz M; Leach J; Jones B; van Vuurden DG; Kramm CM; Fouladi M
J Clin Oncol; 2018 Jul; 36(19):1963-1972. PubMed ID: 29746225
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
4. External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
Veldhuijzen van Zanten SEM; Lane A; Heymans MW; Baugh J; Chaney B; Hoffman LM; Doughman R; Jansen MHA; Sanchez E; Vandertop WP; Kaspers GJL; van Vuurden DG; Fouladi M; Jones BV; Leach J
J Neurooncol; 2017 Aug; 134(1):231-240. PubMed ID: 28560664
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
[TBL] [Abstract][Full Text] [Related]
7. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.
Lober RM; Cho YJ; Tang Y; Barnes PD; Edwards MS; Vogel H; Fisher PG; Monje M; Yeom KW
J Neurooncol; 2014 Mar; 117(1):175-82. PubMed ID: 24522717
[TBL] [Abstract][Full Text] [Related]
9. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).
Bailey S; Howman A; Wheatley K; Wherton D; Boota N; Pizer B; Fisher D; Kearns P; Picton S; Saran F; Gibson M; Glaser A; Connolly DJ; Hargrave D
Eur J Cancer; 2013 Dec; 49(18):3856-62. PubMed ID: 24011536
[TBL] [Abstract][Full Text] [Related]
10. A homogeneous treatment for non-DIPG diffuse midline glioma.
Schiavello E; Biassoni V; Gattuso G; Podda M; Chiaravalli S; Barretta F; Antonelli M; De Cecco L; Pecori E; Gandola L; Massimino M
Tumori; 2023 Jun; 109(3):269-275. PubMed ID: 35708347
[TBL] [Abstract][Full Text] [Related]
11. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.
Khuong-Quang DA; Buczkowicz P; Rakopoulos P; Liu XY; Fontebasso AM; Bouffet E; Bartels U; Albrecht S; Schwartzentruber J; Letourneau L; Bourgey M; Bourque G; Montpetit A; Bourret G; Lepage P; Fleming A; Lichter P; Kool M; von Deimling A; Sturm D; Korshunov A; Faury D; Jones DT; Majewski J; Pfister SM; Jabado N; Hawkins C
Acta Neuropathol; 2012 Sep; 124(3):439-47. PubMed ID: 22661320
[TBL] [Abstract][Full Text] [Related]
12. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.
Chiang J; Diaz AK; Makepeace L; Li X; Han Y; Li Y; Klimo P; Boop FA; Baker SJ; Gajjar A; Merchant TE; Ellison DW; Broniscer A; Patay Z; Tinkle CL
Acta Neuropathol Commun; 2020 Apr; 8(1):57. PubMed ID: 32326973
[TBL] [Abstract][Full Text] [Related]
13. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.
Castel D; Philippe C; Calmon R; Le Dret L; Truffaux N; Boddaert N; Pagès M; Taylor KR; Saulnier P; Lacroix L; Mackay A; Jones C; Sainte-Rose C; Blauwblomme T; Andreiuolo F; Puget S; Grill J; Varlet P; Debily MA
Acta Neuropathol; 2015 Dec; 130(6):815-27. PubMed ID: 26399631
[TBL] [Abstract][Full Text] [Related]
14. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.
Jansen MH; Veldhuijzen van Zanten SE; Sanchez Aliaga E; Heymans MW; Warmuth-Metz M; Hargrave D; van der Hoeven EJ; Gidding CE; de Bont ES; Eshghi OS; Reddingius R; Peeters CM; Schouten-van Meeteren AY; Gooskens RH; Granzen B; Paardekooper GM; Janssens GO; Noske DP; Barkhof F; Kramm CM; Vandertop WP; Kaspers GJ; van Vuurden DG
Neuro Oncol; 2015 Jan; 17(1):160-6. PubMed ID: 24903904
[TBL] [Abstract][Full Text] [Related]
15. Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients.
Wang Y; Pan C; Xie M; Zuo P; Li X; Gu G; Li T; Jiang Z; Wu Z; Zhang J; Zhang L
J Neurosurg; 2022 Dec; 137(6):1628-1638. PubMed ID: 35395636
[TBL] [Abstract][Full Text] [Related]
16. Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas.
Puget S; Beccaria K; Blauwblomme T; Roujeau T; James S; Grill J; Zerah M; Varlet P; Sainte-Rose C
Childs Nerv Syst; 2015 Oct; 31(10):1773-80. PubMed ID: 26351229
[TBL] [Abstract][Full Text] [Related]
17. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
Hennika T; Becher OJ
J Child Neurol; 2016 Oct; 31(12):1377-85. PubMed ID: 26374787
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
[TBL] [Abstract][Full Text] [Related]
20. Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.
Maxwell R; Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Bettegowda C; Jallo GI; Terezakis SA; Groves ML
World Neurosurg; 2018 Nov; 119():e1006-e1015. PubMed ID: 30138731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]